Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanya Fischer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Canadian Journal of Hospital Pharmacy|January 25, 2021
Patient Factors Associated with Prescribing of Iron for IV Administration: A Descriptive StudyThomas Brownlee, Deonne Dersch-Mills, Ginny Cummings, et al.
Advances in Therapy|December 5, 2024
Pharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese VolunteersXiaodong Wang, Rachel Kirk, Mark Matijevic, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
QIM25-225: Do Oncology Patients Want to Know Both Generic and Brand Drug Names?Laura Hanisch, Erin Vidic, Tanya Fischer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 8, 2023
The Value and Process of Inclusion: Using Sensitive, Respectful, and Inclusive Language and Images in NCCN ContentDeborah A Freedman-Cass, Tanya Fischer, Ash B Alpert, et al.
Orphanet Journal of Rare Diseases|April 17, 2020
Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseasesNicole Lyn, Ruth Pulikottil-Jacob, Camille Rochmann, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Canadian Journal of Hospital Pharmacy|January 25, 2021
Patient Factors Associated with Prescribing of Iron for IV Administration: A Descriptive StudyThomas Brownlee, Deonne Dersch-Mills, Ginny Cummings, et al.
Advances in Therapy|December 5, 2024
Pharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese VolunteersXiaodong Wang, Rachel Kirk, Mark Matijevic, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
QIM25-225: Do Oncology Patients Want to Know Both Generic and Brand Drug Names?Laura Hanisch, Erin Vidic, Tanya Fischer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 8, 2023
The Value and Process of Inclusion: Using Sensitive, Respectful, and Inclusive Language and Images in NCCN ContentDeborah A Freedman-Cass, Tanya Fischer, Ash B Alpert, et al.
Orphanet Journal of Rare Diseases|April 17, 2020
Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseasesNicole Lyn, Ruth Pulikottil-Jacob, Camille Rochmann, et al.
Pageof 1